Journal of Microbiology and Biotechnology
The Korean Society for Microbiology and Biotechnology publishes the Journal of Microbiology and Biotechnology.
 
Research Misconduct Policy


Research Misconduct Policy of KMB

(Established on 3rd of June, 2011)
Article 1.(Purpose)

The purpose of this Research Misconduct Policy (RMP) is to prevent any misconduct related to research conducted and disseminated in journals and at symposiums of the Korean Society for Microbiology and Biotechnology (KMB) and to detail the fundamental principles and structural procedures related to research integrity which are required to ensure research ethics.

Article 2 (Policy Subjects)

This RMP applies to articles printed in journals published by KMB and to abstracts published for symposiums.

Article 3.(The range of research misconduct)

Research misconduct in this RMP is defined as constituting any of the following:

① Fabrication: The creation of false information about non-existent data or findings.
② Falsification: The artificial manipulation of research materials, equipment, and processes; and/or the modification or deletion of data resulting in distorted research or research results.
③ Plagiarism: The use of another's written work, spoken ideas, research work and/or research results, without properly attributing correct authorship.
④ Improper Authorship: An author is scientifically and technically unqualified to be an author of the relevant work, or an author has not contributed meaningfully to the work.
⑤ Interfering with an Investigation: Any act which hinders or disrupts a research misconduct investigation being conducted under this RMP.
⑥ Evaluator Misconduct: Giving an unfair evaluation of research submitted for publication during the evaluation process; and/or disclosing or plagiarizing ideas from submitted research; and/or acquiring rights to ideas or methods obtained from submitted research.
⑦ Aberrant Acts: Any acts which the majority of members of the international scientific technology community would find to be severely unethical.

Article 4 (Commencement of Investigation)

Only the Research Integrity Committee of KMB may commence a research misconduct investigation, and may do so in the following situations:

① An allegation of research misconduct falling within the scope of this RMP (Article 3) has been made by an affected party.
② An editorial or academic board is of the view that research misconduct may have occurred.
③ There is deemed to be a need for a second research misconduct investigation if significant defects in an initial investigation are suspected.
④ A request for an investigation from an external organization has been received.

Article 5 (Protection of Informants)

① An informant in this RMP refers to any person who makes an allegation of research misconduct; and/or who submits evidence of said misconduct to the Research Integrity Committee of KMB.
② Submitted evidence of research misconduct is preferred in written form accompanied with the informant's name. However, anonymously submitted information clearly illustrating and detailing the research misconduct will be considered by the Research Integrity Committee.
③ All personal information (including but not limited to names, affiliations, and contact details) about an informant will not be disclosed.
④ The Research Integrity Committee will endeavor to keep an informant up to date regarding the status of the investigation process.
⑤ Informants who are found to have submitted false information will not be protected by the Research Integrity Committee and may be subject to further penalties.

Article 6 (Protection of Interviewee)

① An interviewee in this RMP refers to any person who is being investigated by the Research Integrity Committee for research misconduct.
② The Research Integrity Committee will endeavor not to damage the reputation of an interviewee, and will endeavor to protect their legal rights, during an ongoing research misconduct investigation.
③ The Research Integrity Committee will not make an accusation of research misconduct public until a verdict has been determined.
④ The Research Integrity Committee will endeavor to keep an interviewee up to date regarding the status of the investigation process.

Article 7 (Time Limit)

An accusation of research misconduct which is deemed to have occurred more than 5 years before the reporting date will not be investigated.

Article 8 (Investigation Process)

The Research Integrity Committee will conduct a research misconduct investigation in three stages. The first is meant to check the veracity of the accusation through a preliminary investigation. This is then followed by a full investigation, and then a verdict will be given.

Article 9 (Preliminary investigation)

① A preliminary investigation determines whether an full investigation of research misconduct is warranted. It will commence within 30 days of receipt of the information indicating research misconduct by the Research Integrity Committee.
② A summary verdict can be made without the commencement of an actual investigation if the interviewee admits to the research misconduct during the preliminary investigation.
③ An informant can appeal to the research integrity committee within 30 days after being informed that an interviewee has been denied of his/her misconduct.

Article 10 (Full Investigation)

① A full investigation refers to the process to determine whether there has been any research misconduct.
② The Research Integrity Committee must offer opportunities for informant(s) and interviewee(s) to represent themselves and/or provide evidence.
③ The representations made by informant(s) and interviewee(s) and the Research Integrity Committee's findings must be included in the investigation report.

Article 11. (Verdict)

① A verdict confirms the outcome of an investigation and will be provided for informant(s) and interviewee(s) in writing.
② A verdict should be given within 6 months of the close of the preliminary investigation. The Chair of the Research Integrity Committee can request more time from the President of KMB and thereby extend the investigation period as required.
③ Informant(s) and interviewee(s) can appeal against the verdict within 30 days of receiving information regarding it. The Research Integrity Committee will re-investigated where it is rational and valid to do so.

Article 12 (Records and Disclosure)

① The Chair of the Research Integrity Committee must inform the President of KMB of the details of any full investigation and the verdict.
② The following must be included in the report (Article 13.1) of the full investigation and its verdict.
1. A detailed contents list.
2. The place (journal, symposium etc.) where the alleged research misconduct occurred.
3. A full list of those involved in the conduct of the investigation and their roles.
4. The alleged research misconduct committed and how this directly relates to the interviewee(s).
5. A full list of all the relevant evidence and witnesses.
6. Full details of both preliminary and full investigation outcomes and any appeals to decisions made.
7. The Research Integrity Committee's Verdict and recommendations for disciplinary action.


Supplementary provision

1. (Enforcement date) This policy is effective from June 3rd, 2011.
Copyright © 2009 by the Korean Society for Microbiology and Biotechnology.
All right reserved. Mail to jmb@jmb.or.kr
Online ISSN: 1738-8872    Print ISSN: 1017-7825    Powered by INFOrang.co., Ltd